Trial Profile
Efficacy and safety of urokinase combined with conbercept or triamcinolone acetonide via intravitreal injection in the treatment for vitreous hemorrhage following various retinal disorders
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Apr 2018
Price :
$35
*
At a glance
- Drugs Conbercept (Primary) ; Triamcinolone (Primary) ; Urokinase (Primary)
- Indications Vitreous haemorrhage
- Focus Therapeutic Use
- 12 Apr 2018 New trial record